Japan Medical Dynamic Marketing, INC.
Notice of Approval for Market Segment Change to the Tokyo Stock Exchange Standard Market and Withdrawal of the Plan to Meet Prime Market Listing Maintenance Criteria
Although approval was received to change the market segment, the plan to meet Prime Market criteria has been withdrawn. Going forward, the Company will aim to enhance corporate value through improved profitability, capital efficiency, and strengthened IR following the transition to the Standard market.
Key Figures
- Market Segment Change Date: November 27, 2026
- Post-change Market Segment: TSE Standard Market
- Securities Code: 7600 (no change)
AI要約
Overview of Market Segment Change
Today, the Tokyo Stock Exchange approved the change of the Company's market segment from the Prime Market to the Standard Market. In conjunction with this approval, the Prime Market compliance plan announced on June 3, 2026 has been withdrawn as of today. The post-change market segment will be the TSE Standard Market, and the securities code will remain unchanged (7600).
Future Policy and Impact
While the approval for the market segment change has been received, the Company will focus on strengthening profitability, improving capital efficiency, and enhancing IR and information disclosure, and will continue dialogue with shareholders and investors. The background for the market change includes an intention to reduce uncertainties related to free-float market capitalization and other compliance factors. The Company has withdrawn the Prime Market compliance plan this time and will pursue corporate value enhancement after the transition to the Standard Market.
Japan Medical Dynamic Marketing, INC.
Company overview · Stock price · Financial data · All IR